Weixiang He

机构：Xijing Hospital, Air Force Medical University · ORCID：0000-0002-4366-8321

发表论文 25 篇 · 总被引 713 次 · h-index 13

代表论文

• <p>Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA</p> (2020 · OncoTargets and Therapy · 被引 221)
• Kidney function decline mediates the adverse effects of per- and poly-fluoroalkyl substances (PFAS) on uric acid levels and hyperuricemia risk (2024 · Journal of Hazardous Materials · 被引 77)
• The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP (2023 · Cancer Letters · 被引 53)
• Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate (2020 · Aging · 被引 51)
• NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia (2021 · Clinical Science · 被引 49)
• Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway (2021 · The Prostate · 被引 34)